/
exposure

Comparison

Outcomes

Study design

Possible explanations of heterogeneity (factors to be used
to stratify
analysis)

Boyle,
2003120

Adults
with CVI
including
CEAP C2

Ruscus extracts

Placebo in 20 RCTs, 4-point symptoms
comparator VAD
scores (all studies),
(MPFF, hydroxyethyl
venous capacity (6
r